Key takeaways

  • Ask for population and language scope
  • Ask for model version and benchmark methods
  • Ask how uncertainty is surfaced
  • Ask whether data is used for training and how updates are governed

The short version

The best vendor questions uncover scope, evidence, uncertainty, data handling and control: who was tested, what counts as correct, how the model fails, who reviews it and what happens to recordings. The practical question is not whether the concept can be reduced to a single score or rule, but whether the information is specific enough to support the next clinical or family decision. Articu’s editorial position is to preserve context—target, language, practice level, cueing, recording quality and uncertainty—rather than present false precision.

Ask for population and language scope

Ask for population and language scope. In real speech practice, this distinction matters because the same surface result can come from different causes and can require different responses. A useful record therefore keeps the observation close to its context instead of converting it immediately into a diagnosis or universal recommendation.

NIST — AI Risk Management Framework 1.0 is useful context here. NIST organizes AI risk management around Govern, Map, Measure and Manage, including documented human oversight, evaluation under deployment-like conditions and ongoing monitoring. The lesson is not that every product or clinic must copy one study protocol; it is that claims should stay within the population, language, task and evidence that were actually evaluated.

Ask for model version and benchmark methods

Ask for model version and benchmark methods. In real speech practice, this distinction matters because the same surface result can come from different causes and can require different responses. A useful record therefore keeps the observation close to its context instead of converting it immediately into a diagnosis or universal recommendation.

FDA — Clinical Decision Support Software Guidance is useful context here. FDA guidance emphasizes that clinicians should be able to independently review the basis for recommendations, understand known/unknown inputs and apply their own judgment; it also discusses automation bias. The lesson is not that every product or clinic must copy one study protocol; it is that claims should stay within the population, language, task and evidence that were actually evaluated.

Ask how uncertainty is surfaced

Ask how uncertainty is surfaced. In real speech practice, this distinction matters because the same surface result can come from different causes and can require different responses. A useful record therefore keeps the observation close to its context instead of converting it immediately into a diagnosis or universal recommendation.

ONC — Decision Support Interventions Certification Resource Guide is useful context here. ONC’s DSI transparency framework illustrates the kinds of source attributes, risk management, validation context and public documentation healthcare buyers may reasonably ask of predictive AI systems. The lesson is not that every product or clinic must copy one study protocol; it is that claims should stay within the population, language, task and evidence that were actually evaluated.

What this means in practice

  • Start with the intended use: what exact decision or repetitive task is the AI helping with?
  • Require visible uncertainty and a usable review path, not only a score.
  • Check performance on the age, language, dialect, speech targets and recording conditions you actually serve.
  • Keep model output, clinician confirmation and later corrections distinguishable in the audit trail.

What technology can help with—and where it stops

Technology can reduce repetitive listening, organize attempts, check recording quality and surface patterns for review. It cannot make an unsupported model clinically valid, erase dataset bias, or replace the professional reasoning required to assess a child. A responsible system makes its scope, model version, uncertainty and limitations visible.

Questions to ask before acting on the output

Ask what population and task the system was validated on, what the model does when it is uncertain, which version produced the result, whether a clinician can inspect the supporting evidence, and how corrections are recorded. For any feature that can influence documentation or clinical decisions, the workflow should make disagreement easy and preserve a human-owned final decision.

The Articu perspective

Articu’s product principle is AI assists; the SLP decides. The useful unit is not an unexplained accuracy score but a structured attempt with its target, language, position, recording quality, confidence/review state and clinician-confirmed label when review occurs.

Sources and further reading

Editorial status: Draft prepared from current literature and authoritative guidance; clinical reviewer pending.

Educational disclaimer: This article is general educational information, not an assessment, diagnosis, or individualized treatment plan. Speech development varies by age, language, dialect, hearing, motor and developmental context. For individual concerns, consult a qualified speech-language pathologist.